This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sugimoto, K.
Right arrow Articles by Chang, K.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sugimoto, K.
Right arrow Articles by Chang, K.-M.

 Previous Article  |  Next Article 

Journal of Virology, June 2005, p. 6976-6983, Vol. 79, No. 11
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.11.6976-6983.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Strain-Specific T-Cell Suppression and Protective Immunity in Patients with Chronic Hepatitis C Virus Infection

Kazushi Sugimoto,1,{dagger} David E. Kaplan,1,{dagger} Fusao Ikeda,1 Jin Ding,1 Jonathan Schwartz,2 Frederick A. Nunes,3 Harvey J. Alter,4 and Kyong-Mi Chang1*

Division of Gastroenterology, Department of Medicine, University of Pennsylvania, and Philadelphia Veterans Affairs Medical Center,1 Pennsylvania Hospital, Philadelphia, Pennsylvania,3 Oregon Health Sciences University, Portland, Oregon,2 Department of Transfusion Medicine, National Institutes of Health, Bethesda, Maryland4

Received 22 July 2004/ Accepted 26 January 2005

Hepatitis C virus (HCV) frequently persists with an apparently ineffective antiviral T-cell response. We hypothesized that some patients may be exposed to multiple HCV subtypes and that strain-specific T cells could contribute to the viral dynamics in this setting. To test this hypothesis, CD4 T-cell responses to three genotype 1a-derived HCV antigens and HCV antibody serotype were examined in chronically HCV infected (genotypes 1a, 1b, 2, 3, and 4) and spontaneously HCV recovered subjects. Consistent with multiple HCV exposure, 63% of patients infected with genotypes 2 to 4 (genotypes 2-4) and 36% of those infected with genotype 1b displayed CD4 T-cell responses to 1a-derived HCV antigens, while 29% of genotype 2-4-infected patients showed serotype responses to genotype 1. Detection of 1a-specific T cells in patients without active 1a infection suggested prior self-limited 1a infection with T-cell-mediated protection from 1a but not from non-1a viruses. Remarkably, CD4 T-cell responses to 1a-derived HCV antigens were weakest in patients with homologous 1a infection and greater in non-1a-infected patients: proportions of patients responding were 19% (1a), 36% (1b), and 63% (2-4) (P = 0.0006). Increased 1a-specific CD4 T-cell responsiveness in non-1a-infected patients was not due to increased immunogenicity or cross-reactivity of non-1a viruses but directly related to sequence divergence. We conclude that the T-cell response to the circulating virus is either suppressed or not induced in a strain-specific manner in chronically HCV infected patients and that, despite their ability to clear one HCV strain, patients may be reinfected with a heterologous strain that can then persist. These findings provide new insights into host-virus interactions in HCV infection that have implications for vaccine development.

* Corresponding author. Mailing address: Department of Medicine, GI Division, University of Pennsylvania, and Philadelphia VAMC, A212 Medical Research, PVAMC, University and Woodland Avenues, Philadelphia, PA 19104. Phone: (215) 823-5893. Fax: (215) 823-4394. E-mail: kmchang{at}mail.med.upenn.edu.

{dagger} Both K.S. and D.E.K. contributed equally to this work and share first coauthorship.

Journal of Virology, June 2005, p. 6976-6983, Vol. 79, No. 11
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.11.6976-6983.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Bukh, J., Thimme, R., Meunier, J.-C., Faulk, K., Spangenberg, H. C., Chang, K.-M., Satterfield, W., Chisari, F. V., Purcell, R. H. (2008). Previously Infected Chimpanzees Are Not Consistently Protected against Reinfection or Persistent Infection after Reexposure to the Identical Hepatitis C Virus Strain. J. Virol. 82: 8183-8195 [Abstract] [Full Text]  
  • Ebinuma, H., Nakamoto, N., Li, Y., Price, D. A., Gostick, E., Levine, B. L., Tobias, J., Kwok, W. W., Chang, K.-M. (2008). Identification and In Vitro Expansion of Functional Antigen-Specific CD25+ FoxP3+ Regulatory T Cells in Hepatitis C Virus Infection. J. Virol. 82: 5043-5053 [Abstract] [Full Text]  
  • Shalev, I., Liu, H., Koscik, C., Bartczak, A., Javadi, M., Wong, K. M., Maknojia, A., He, W., Liu, M. F., Diao, J., Winter, E., Manuel, J., McCarthy, D., Cattral, M., Gommerman, J., Clark, D. A., Phillips, M. J., Gorczynski, R. R., Zhang, L., Downey, G., Grant, D., Cybulsky, M. I., Levy, G. (2008). Targeted Deletion of fgl2 Leads to Impaired Regulatory T Cell Activity and Development of Autoimmune Glomerulonephritis. J. Immunol. 180: 249-260 [Abstract] [Full Text]  
  • Racanelli, V., Frassanito, M. A., Leone, P., Brunetti, C., Ruggieri, S., Dammacco, F. (2007). Bone Marrow of Persistently Hepatitis C Virus-Infected Individuals Accumulates Memory CD8+ T Cells Specific for Current and Historical Viral Antigens: A Study in Patients with Benign Hematological Disorders. J. Immunol. 179: 5387-5398 [Abstract] [Full Text]  
  • Neumann-Haefelin, C., Thimme, R. (2007). CD4+ T cells don't always help. Blood 110: 1408-1409 [Full Text]  
  • Schulze zur Wiesch, J., Lauer, G. M., Timm, J., Kuntzen, T., Neukamm, M., Berical, A., Jones, A. M., Nolan, B. E., Longworth, S. A., Kasprowicz, V., McMahon, C., Wurcel, A., Lohse, A. W., Lewis-Ximenez, L. L., Chung, R. T., Kim, A. Y., Allen, T. M., Walker, B. D. (2007). Immunologic evidence for lack of heterologous protection following resolution of HCV in patients with non genotype 1 infection. Blood 110: 1559-1569 [Abstract] [Full Text]  
  • Holmes, D., Knudsen, G., Mackey-Cushman, S., Su, L. (2007). FoxP3 Enhances HIV-1 Gene Expression by Modulating NF{kappa}B Occupancy at the Long Terminal Repeat in Human T Cells. J. Biol. Chem. 282: 15973-15980 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»